Pressreleases

INC Research Grows Clinical Trials Services Team in India to Manage Growing Demands in Emerging Region

New leadership in Gurgaon office further strengthens clinical trials outsourcing services and data operations.

INC Research Adds AVOS Life Sciences to Strengthen Strategic and Regulatory Consulting Group

Powerhouse team expands consulting capabilities with unparalleled expertise and analytical tools.

Patrick Melvin Joins Oncology Leadership Team at INC Research

Therapeutic and operational clinical trials expert strengthens oncology capabilities.

INC Research Augments Pediatric Clinical Trial Capabilities

Kathy Bohannon brings valuable multi-discipline therapeutic expertise to pediatric trial design and management.

INC Research Sponsors FierceBiotech Clinical Insights Executive Breakfast on Designing the Ideal Phase II Trial

Exclusive gathering to feature expert panel offering perspectives on the latest trends and technologies for mid-stage studies.

SHL Continues to Expand Taiwan Facilities to Support Auto Injector Production

SHL has just completed an additional expansion of its Nan Kan 6 facility located in northern Taiwan to ensure that adequate production capacity can be maintained for its OEM/ODM customers. CNC, Molding, and Automation related production have been added to the facility, expanding on our support for these key in-house capabilities. In particular, this facility will house extensive CNC lines which will be utilized by SHL Automation to support production of automated testing and assembly equipment for our medical devices. In addition, these CNC lines will be utilized by SHL Technologies to support its growing need for precision machined components and modules.

Rhenovia Wins Contract to Lead USD 3.75 Million Biosimulation Project

Collaborative project extends Rhenovia’s innovative CNS biosimulation platform to study of epilepsy.

Rhenovia Signs Two-Year EUR 500,000 Partnership with AFM to Support its Simulation Technology for Diseases of the Nervous System

This strategic agreement will help accelerate development of Rhenovia’s unique technology and enable AFM to explore new avenues for the treatment of neurological diseases.

Rhenovia Signs an R&D Contract with Sodiaal-Candia for Studying the Nutritional and Therapeutic Value of Milk and Its Derivatives

Strategic contract will enable Rhenovia to apply its pharmaceutical research know-how to develop activities in the health food and supplements market.